This week, from June 15th to 18th, one new stock is scheduled for subscription, barring any changes, according to current arrangements. This is a new share on the Beijing Stock Exchange.
As of the time of writing, the issue price has been disclosed for one new stock to be offered online this week. The Beijing Stock Exchange-listed Kelairedi has set its issue price at 15.62 yuan, with a price-to-earnings ratio of 19.62 times. The industry's average dynamic P/E ratio for the most recent month is 47.22 times.
Kelairedi, which begins its subscription on June 15th, is a provider of supporting medical device solutions in the fields of radiotherapy and rehabilitation therapy. Its main business involves the research, development, production, and sales of radiotherapy positioning devices for tumor radiation therapy and rehabilitation assistive devices for rehabilitation treatment. After more than two decades of development, Kelairedi has established three major technology platforms—foundational material technology, product application technology, and intelligent technology—based on its core technology in medical low-temperature thermoplastic materials. This has resulted in two main product series centered around radiotherapy and rehabilitation therapy. For this IPO, Kelairedi aims to raise a total of 231 million yuan.
It is noteworthy that, as of now, three companies are scheduled for their initial IPO review meetings this week (June 15th to 18th). These are Suiyuan Technology, aiming for the STAR Market, Yuexin Semiconductor, targeting the ChiNext board, and Futaihe, seeking a listing on the Beijing Stock Exchange.
Suiyuan Technology, facing its IPO review on June 15th, is one of China's leading companies in the field of cloud AI chips, striving to become a "leader in general artificial intelligence infrastructure." Over its eight-year history, the company has independently developed and iterated four generations of architecture, resulting in five models of cloud AI chips. It has built a comprehensive product system covering AI chips, AI accelerator cards and modules, intelligent computing systems and clusters, and AI computing and programming software platforms. In terms of core technologies, Suiyuan Technology has, through years of accumulation, formed a comprehensive, three-dimensional core technology system comprising chips and hardware, software and programming platforms, and computing power cluster solutions. Regarding computing power clusters, the company has already generated revenue from thousand-card and ten-thousand-card intelligent computing center projects during the reporting period. Currently, the company is collaborating with clients to develop super-node solutions and jointly build commercially viable ten-thousand-card high-speed interconnection clusters. For this IPO, Suiyuan Technology plans to raise 6 billion yuan.
Yuexin Semiconductor, also facing its IPO review on June 15th, is an integrated circuit manufacturing enterprise dedicated to providing 12-inch wafer foundry services and specialty process solutions for domestic and international chip design companies. The company's core business model is specialty process wafer foundry, serving chip design companies and end customers. Its main clientele includes several top-tier semiconductor design companies both within and outside China. Yuexin Semiconductor currently operates two 12-inch wafer fabs: the first factory (Yuexin Phase I & II) and the second factory (Yuexin Phase III), with a combined planned capacity of 80,000 wafers per month. As of the end of 2025, it had achieved a production capacity of 63,300 wafers per month. Presently, the company has commenced construction on a third factory (Yuexin Phase IV), a 12-inch integrated circuit digital-analog mixed-signal specialty process production line with a planned capacity of 40,000 wafers per month. Upon completion of Yuexin Phase IV, the company's total capacity will reach 120,000 wafers per month. For this IPO, Yuexin Semiconductor plans to raise 7.5 billion yuan.
Comments